共 50 条
- [1] A 'real-world' observational multi-centre study comparing the side effects and patient acceptability of budesonide MMX with prednisolone in patients with mild to moderate ulcerative colitis [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S663 - S664
- [2] A prospective multi-centre observational cohort study assessing the effectiveness of Budesonide MMX® for mild-to-moderate ulcerative colitis [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S296 - S297
- [4] Budesonide MMX versus Prednisolone for Ulcerative Colitis: Comparative outcomes from a British retrospective multi-centre study [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S327 - S327
- [5] Real-world effectiveness of tofacitinib in ulcerative colitis: a multi-centre study [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S274 - S275
- [6] Assessment of the effectiveness of Budesonide MMX® for active, mild-to-moderate ulcerative colitis in the Polish sub-group of the CORE Practice prospective multi-centre observational study [J]. GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, 2023, 18 (02): : 154 - 160
- [7] Real-World Effectiveness And Safety Of Ustekinumab In Patients With Ulcerative Colitis: A Multi-Centre Study [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S349 - S350
- [8] Golimumab in ulcerative colitis: A multi-centre real-world experience [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S422 - S423
- [9] A 'real-world' retrospective multi-centre study comparing infliximab and adalimumab for the maintenance of remission in ulcerative colitis [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S480 - S480